4. Resultater - Institutleder til klinisk medicin - Aarhus Universitet
4. Resultater - Institutleder til klinisk medicin - Aarhus Universitet
4. Resultater - Institutleder til klinisk medicin - Aarhus Universitet
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
33. Wapner R. et al. First-Trimester Screening for Trisomies 21 and 18. The New England<br />
Journal of Medicine 2003;349: 1405-1413.<br />
3<strong>4.</strong> De Biasio P. et al. First-trimester Screening for Down Syndrome Using Nuchal<br />
Transluency Measurement with Free β-hCG and PAPP-A Between 10 and 13 Weeks<br />
of Pregnancy – the Combined Test. Prenatal Diagnosis 1999;19: 360-363.<br />
35. von Kaisenberg CS. Screening for trisomy 21 by maternal age, fetal nuchal<br />
translucency and maternal serum biochemistry at 11-14 weeks: a German multicenter<br />
study. The Journal of Maternal-Fetal and Neonatal Medicine 2002;12: 89-9<strong>4.</strong><br />
36. Borrell A. et al. First-trimester screening for trisomy 21 combining biochemistry and<br />
ultrasound at individually optimal gestational ages. An interventional study. Prenatal<br />
Diagnosis 2004;24: 541-545.<br />
37. Soergel P. Screening for Trisomy 21 with Maternal Age, Fetal Nuchal Translucency<br />
and Maternal Serum Biochemistry at 11-14 Weeks: A Regional Experience from<br />
Germany. Fetal Diagnosis and Therapy 2006;21: 264-268.<br />
38. Tabor A, Uldbjerg N. Et nyt <strong>til</strong>bud <strong>til</strong> alle gravide: screening for Downs syndrom og<br />
medfødte misdannelser. Ugeskr Læger 2005;167: 1399.<br />
39. Risikovurdering og fosterdiagnostik – Information <strong>til</strong> gravide. Sundhedsstyrelsen og<br />
Komiteen for Sundhedsoplysning. 1. udgave, 1. oplag, 200<strong>4.</strong><br />
40. Nicolaides KH. et al. One-stop clinic for assessment of risk of chromosomal defects at<br />
week 12 of gestation. The Journal of Maternal-Fetal and Neonatal Medicine 2002;12:<br />
9-18.<br />
41. Christiansen M. et al. Total pregnancy-associated plasma protein A- a first trimester<br />
maternal marker for Down’s syndrome: clinical and technical assessment of a polymonoclonal<br />
enzyme immunoassay. Scand J Clin Lab Invest 2003;63: 407-416.<br />
42. Schiøtt KM. et al. The ”Consecutive Combined test” – using Double Test from week<br />
8+0 and Nuchal Transluency Scan, for first trimester screening for Down Syndrome.<br />
Upubliceret materiale.<br />
43. Uldbjerg N. Undervisnings materiale, Prænatal diagnostik.<br />
http://www.sundhed.dk/Images/alle/amt_aarhus/pdf/Skejby_Sygehus/Afdelinger/Beha<br />
ndlingsafdelinger/Gynaekologisk_Obstetrisk_Afdeling_Y/uddannelse_praenatal_diag<br />
nostik.pdf. 30-10-2005.<br />
4<strong>4.</strong> Saugmann-Jensen P.<br />
http://www.sst.dk/upload/<strong>til</strong>syn/bio<strong>medicin</strong>/fosterdiagnostik/down-born.pdf<br />
45. Hertz JM. Faglig samtale med Overlæge dr. med Jens Michael Hertz, Klinisk Genetisk<br />
Afdeling, Århus Sygehus.<br />
46. Matzen P. et al. Evidensbaseret <strong>medicin</strong>. In: Hansen NE, Haunsø S, Schaffalitzky de<br />
Muckadell OB, editors. Medicinsk kompendium bind 1. København: Nyt Nordisk<br />
Forlag Arnold Busck, 2004: 12-23.<br />
47. Juul S. Epidemiologi og evidens. 1 ed. Kbh.: Munksgaard, 2005.<br />
37
Change language